AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
15 Nov 2012 04:30 PM
RNS
Director/PDMR Shareholding
14 Nov 2012 04:49 PM
RNS
FORXIGA first in class SGLT2 gets EU approval
12 Nov 2012 04:30 PM
RNS
Definition of Core Financial Measures
12 Nov 2012 07:00 AM
RNS
Top-line phase III results for Naloxegol
01 Nov 2012 03:00 PM
RNS
Total Voting Rights
29 Oct 2012 01:10 PM
RNS
Director/PDMR Shareholding
29 Oct 2012 01:10 PM
RNS
Director/PDMR Shareholding
25 Oct 2012 07:00 AM
RNS
3rd Quarter Results
24 Oct 2012 09:00 AM
RNS
Notice of Results
01 Oct 2012 04:30 PM
RNS
Total Voting Rights
01 Oct 2012 02:00 PM
RNS
AstraZeneca suspends share repurchase programme
26 Sep 2012 07:00 AM
RNS
Transaction in Own Shares
25 Sep 2012 07:00 AM
RNS
Transaction in Own Shares
19 Sep 2012 08:48 AM
RNS
Transaction in Own Shares
18 Sep 2012 07:00 AM
RNS
Transaction in Own Shares
17 Sep 2012 07:00 AM
RNS
Transaction in Own Shares
14 Sep 2012 07:00 AM
RNS
Transaction in Own Shares
12 Sep 2012 07:00 AM
RNS
AstraZeneca prices a $2 billion bond issue
11 Sep 2012 07:00 AM
RNS
Transaction in Own Shares
10 Sep 2012 07:00 AM
RNS
Transaction in Own Shares
07 Sep 2012 07:00 AM
RNS
Transaction in Own Shares
06 Sep 2012 07:00 AM
RNS
Transaction in Own Shares
05 Sep 2012 07:00 AM
RNS
Transaction in Own Shares
04 Sep 2012 07:00 AM
RNS
Transaction in Own Shares
03 Sep 2012 04:00 PM
RNS
Total Voting Rights
03 Sep 2012 07:00 AM
RNS
Transaction in Own Shares
31 Aug 2012 05:00 PM
RNS
Director/PDMR Shareholding
31 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
30 Aug 2012 05:00 PM
RNS
Director/PDMR Shareholding
30 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
29 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
28 Aug 2012 07:00 AM
RNS
European Commission approves Zinforo
28 Aug 2012 07:00 AM
RNS
Pascal Soriot appointed CEO
28 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
24 Aug 2012 04:00 PM
RNS
Director/PDMR Shareholding
24 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
23 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
22 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
21 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
20 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
17 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
15 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
14 Aug 2012 07:00 AM
RNS
Partners Pfizer for over-the-counter Nexium
09 Aug 2012 12:45 PM
RNS
Bristol-Myers Squibb completes purchase of Amylin
06 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
03 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
02 Aug 2012 07:00 AM
RNS
Transaction in Own Shares
01 Aug 2012 04:00 PM
RNS
Total Voting Rights
01 Aug 2012 02:00 PM
RNS
Director/PDMR Shareholding
01 Aug 2012 07:00 AM
RNS
Transaction in Own Shares

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings